Acadia Healthcare (NASDAQ:ACHC) Announces Quarterly Earnings Results, Beats Expectations By $0.14 EPS

Acadia Healthcare (NASDAQ:ACHC) posted its quarterly earnings results on Wednesday. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.14, FiscalAI reports. The business had revenue of $895.31 million during the quarter, compared to the consensus estimate of $877.76 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. Acadia Healthcare’s revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.72 EPS.

Acadia Healthcare Stock Up 8.9%

Shares of NASDAQ:ACHC traded up $2.63 during mid-day trading on Wednesday, hitting $32.25. 5,055,130 shares of the company traded hands, compared to its average volume of 1,622,090. The stock has a market cap of $3.00 billion, a P/E ratio of -2.59, a P/E/G ratio of 9.54 and a beta of 0.64. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $35.83. The stock has a 50-day moving average price of $29.18 and a two-hundred day moving average price of $25.91.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ACHC. Raymond James Financial lowered shares of Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price objective on the stock. in a research note on Monday, September 28th. TD Cowen lifted their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Guggenheim boosted their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a report on Tuesday, October 6th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Acadia Healthcare currently has an average rating of “Hold” and an average target price of $30.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.